Tarsus Pharmaceuticals
TARS
TARS
148 hedge funds and large institutions have $1.09B invested in Tarsus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
24% less capital invested
Capital invested by funds: $1.43B → $1.09B (-$340M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
90% less call options, than puts
Call options by funds: $2.26M | Put options by funds: $22M
Holders
148
Holding in Top 10
4
Calls
$2.26M
Puts
$22M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$16.7M | |
| 3 | +$12.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.4M |
| 5 |
Millennium Management
New York
|
+$8.78M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$14M | |
| 3 | -$13.8M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$11.6M |
| 5 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$10.7M |